4Geagea A,Cellier C.Scope of drug-induced,infectious and allergic esophageal injury[J].Curr Opin Gastroenterol.2008,24(4):496-50.
5Pereira GA,Genaro PS,Santos LC,et al.Validation of a food frequency questionnaire for women with osteoporosis[J].J Nutr Health Aging,2009,13(5):403-7.
6Van Brussel MS,Bultink IE,Lems WF.Prevention of glucocorticoid-induced osteoporosis[J].Expert Opin Pharmacother.2009,10(6):997-1005.
3Reid IR, Brown JP, Burckhardt P, et al. Intravenous zoledronic acid in postmenopausal women with low bone mineral density[J]. N Engl J Med, 2002, 346(9) :653-661.
4Gallagher JC, Baylink DJ, Freeman R & Mc Clung MR. Prevention of bone loss with tibolone in postmenopausal women: results form the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluationl [J]. Journal of Clinical Endocrinology and Metabolism, 2001,86(10) :4717-4726.
